German Isatuximab Cited by user CreatorDavid on 02 Jan 2024 Isatuximab, Markennamen Sarclisa; Hersteller Sanofi), ist ein monoklonaler Antikörper (mAb)-Wirkstoff zur Behandlung von Multiplem Myelom.
Japanese イサツキシマブ Cited by user Utataneko on 11 Oct 2021 イサツキシマブ(Isatuximab)は、多発性骨髄腫の治療のためのモノクローナル抗体の医薬品である。開発コード:SAR650984。.
English Isatuximab Cited by user Alchero on 20 Mar 2020 Isatuximab is a monoclonal antibody (mAb) designed for the treatment of cancer. It was developed by ImmunoGen and Sanofi-Aventis with the development name SAR-650984.